Neogenomics Inc expected to post breakeven results a share - Earnings Preview

NeoGenomics

26/07/2024 21:33

* Neogenomics Inc  NEO.OQ   NEO.O  is expected to show a
rise in
quarterly revenue when it reports  results on July 29 for the
period ending June 30 2024
    * The Fort Myers Florida-based  company is expected to
report a
10.2% increase in revenue to $161.847 million from $146.92
million a year ago, according to the mean estimate from 13
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Neogenomics Inc is for
breakeven results per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neogenomics
Inc
is $19.00​, above​ its last closing price of $15.08. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.04       -0.05      -0.02     Beat    59.3
 Dec. 31 2024  -0.01       -0.02      0.03      Beat    220.4
 Sep. 30 2023  -0.06       -0.07      0.00      Beat    100​
 Jun. 30 2023  -0.11       -0.11      -0.05     Beat    56
 ​​Jan.        -0.15       -0.15      -0.09     Beat    40.5
 1 0001                                                 
 Dec. 31 2022  -0.15       -0.16      -0.06     Beat    63.6​
 Sep. 30 2022  -0.20       -0.21      -0.14     Beat    32
 Jun. 30 2022  -0.20       -0.23      -0.16     Beat    29
 This summary was machine generated July 26 at 20:33 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)